Celyad Oncology S.A. logo

Celyad Oncology S.A. (0QFK)

Market Closed
LSE LSE
4.46M Market Cap
- P/E Ratio
- Div Yield
- Volume
- Eps
Previous Close
Day Range
0 0
Year Range
0 0
Want to track 0QFK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

0QFK is not paying dividends to its shareholders.
The last earnings report, released on Nov 06, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on XBRU (EUR).

0QFK Chart

Similar

ROQ
Roquefort Therapeutics Plc
1.4 GBX
0%
EVG
Evgen Pharma PLC
0.82 GBX
+2.25%
Bsf Enterprise Plc
2.1 GBX
-10.64%

Celyad Oncology S.A. (0QFK) FAQ

What is the stock price today?

The current price is €0.00.

On which exchange is it traded?

Celyad Oncology S.A. is listed on XBRU.

What is its stock symbol?

The ticker symbol is 0QFK.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.46M.

Has Celyad Oncology S.A. ever had a stock split?

No, there has never been a stock split.

Celyad Oncology S.A. Profile

Biotechnology Industry
Healthcare Sector
- CEO
LSE Exchange
BE0974260896 ISIN
France Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Contact Information

Address: -
Phone: -